You are here

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoporosis
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Post menopausal women subjects with Osteoporosis who has no experience of use of
Bazedoxifene.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subject with present or past venous thromboembolism such as deep venous thrombosis,
pulmonary embolism, or retinal venous thrombosis

- Subject in long-term immovability (postoperative recovery, long-term bed rest)

- Subject with antiphospholipid antibody syndrome

NCT01470326
Pfizer
Completed
Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Osteoporosis
NCT00774267
Females
40+
Years
Multiple Sites
Osteopenia, Osteoporosis, Bone Disease
NCT01293487
All Genders
55+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now